• Non ci sono risultati.

A new device for the hand BMD measurement (ALARA METRISCAN): a clinical evaluation

N/A
N/A
Protected

Academic year: 2021

Condividi "A new device for the hand BMD measurement (ALARA METRISCAN): a clinical evaluation"

Copied!
1
0
0

Testo completo

(1)

A NEW DEVICE FOR THE HAND BMD MEASUREMENT (ALARA METRISCAN):

A CLINICAL EVALUATION

R. Valenti, G. Martini, E. Ceccarelli, N. Dal Canto, R. Nuti

Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy

DEXA is now considered the “goal standard” for bone mineral density assessment.

Nowadays, this technique is available for evaluation of several skeletal sites (lumbar spine, hip, radius and heel). A new X-ray absorptiometry device for finger BMD measurement has recently presented, called Alara Metriscan. Alara Metriscan use an X-ray digital technique that allow the BMD evaluation of the middle phalanx of the second, third and fourth finger of the left hand. This device is quickly, easy to use, and relatively cheaper to respect the other techniques. Furthermore, the radiation exposure for sin-gle scan is very low (0.012 mSV for a sinsin-gle scan).

The aim of the present study was to evaluate the diagnostic accuracy and the reproducibility of the new BMD device Alara Metriscan. We evaluate 218 patients (190 females, mean age 60±9, and 28 males, mean age 65±8), by lumbar spine, proximal hip, total hand, and finger QUS and we compared our results with Alara Metriscan data.

Reproducibility was evaluated as C.V.% after 3 consecutive measurements with repositioning of the left hand.

Diagnostic accuracy was evaluated on the basis of BMD T-Score: we considered as osteoporotic the sub-ject with L1-L4 T-Score or and/or hip T-Score • –2.5, than we calculated the percentage of patients prop-erly diagnosed with Alara Metriscan. Among 60 osteoporotic patients, 22 patients had a T-Score • –2.5 (33%) at Alara, while only 23 of 158 patients classified as non-osteoprotic based on L1-L4 or hip T-Score were incorrectly classified as osteoporotic by Alara. In our patients, sensibility and specificity were 36 and 85%, respectively.

As far as the “short-term” reproducibility is concerned, our results gave a coefficient of variation (C.V.) for Alara measurements of 0.8%.

Moreover, in our patients we obtained some interesting data about the relationship with other devices: the finger BMD highly correlated with BMD measured the other sites by DEXA, particularly with the hand, while the correlation appeared slightly weaker with U.S. parameters, but stronger compared with the rela-tionship between U.S. parameters and lumbar and hip data.

In conclusion, Alara Metriscan appeared easy to use, relatively cheaper to respect the other device cur-rently employed for BMD evaluation, mantaining a good accuracy and safety profile, and can be easily used on large scale for screening programs.

248 Clinical Cases in Mineral and Bone Metabolism 2005; 2(3): 185-252

BSTR CT (V Congresso CCMBM) 18/11/2005 15.59 Pagina 248

FOR REVIEW ONLY

Riferimenti

Documenti correlati

compared the effect of enzymatic and acid hydrolysis on different plant protein sources (soybean, rapeseed and guar protein meals), in terms of efficacy against the powdery mildew

Lastly, in the group with a negative family history, no syndromic lesions and single Pheo/PGL (the patients with tumors generally classified as “truly sporadic”) germ-line

L’architetto catalano Enric Miralles, fondatore dello studio EMBT insieme alla moglie italiana Benedetta Ta- gliabue, vinse il concorso nel 1997, con un progetto rispettoso

However, all the tested genomes possess regulatory el- ements affecting the expression of the genes related to virulence: components of AHL-dependent quorum sensing system, 3

The global cluster environment is related to the clustercentric distance and the distance to the nearest X-ray peaks, whereas the local envi- ronment is connected to the local

In a cohort of lung transplanted patients who received a combined CMV prophylaxis scheme we aimed to: (a) evaluate the potential use of a CMV ELISPOT assay to identify patients

The naïve Bayes classifier at the core of the Piacenza score was manually implemented (without any additional machine learning framework used) since an existing algorithm

Retrospectively applying the score to the sample population of 1025 patients, we obtained that 38.1% of patients achieved a score equal to or greater than 15, placing themselves